+20.1%
GSK vs WYNN
-28.3%
+48.5%
-19.3%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | WYNN | Excess | Alpha |
|---|---|---|---|---|
| 1D | 0.0% | -0.8% | +0.8% | +0.1% |
| 7D | -3.5% | -4.2% | +0.7% | -3.0% |
| 30D | -3.4% | -14.6% | +11.2% | -1.4% |
| 3M | -8.1% | -18.4% | +10.3% | -5.6% |
| 6M | -11.1% | -11.9% | +0.8% | -9.7% |
| YTD | +0.7% | -26.6% | +27.3% | +4.4% |
| 1Y | +20.1% | -28.5% | +48.7% | +24.6% |
| All | +20.1% | -28.3% | +48.5% | +24.6% |
Cumulative growth
Daily Returns
Daily percentage return beside WYNN.
Daily Out/Under-Performance
Portfolio return minus WYNN return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × WYNN return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded WYNN wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling